Evidence map›Paper›PMID 37312990›Full record

ArticleRSC advances2023

Investigation of organophosphorus (OPs) compounds by a needle trap device based on mesoporous organo-layered double hydroxide (organo-LDH).

Razzagh Rahimpoor, Danial Soleymani-Ghoozhdi, Saber Alizadeh, Ali Firoozichahak, Faeze Mehregan, Razieh Firoozi

Abstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Razzagh RahimpoorDepartment of Occupational Health Engineering, Research Center for Health Sciences, School of Health, Larestan University of Medical Sciences Larestan Iran.
Danial Soleymani-GhoozhdiStudent Research Committee, Faculty of Public Health, Kerman University of Medical Sciences Kerman Iran.ORCID https://orcid.org/0000-0001-9121-2401
Saber AlizadehDepartment of Chemistry, Bu-Ali-Sina University Hamedan Iran.ORCID https://orcid.org/0000-0003-3731-8365
Ali FiroozichahakDepartment of Occupational Health, Faculty of Health, Social Determinants of Health Research Center, Gonabad University of Medical Science Gonabad Iran a.firoozi@edu.umsha.ac.ir.ORCID https://orcid.org/0000-0003-2325-9368
Faeze MehreganMedical Student, School of Medicine, Shahrekord University of Medical Sciences Shahrekord Iran.
Razieh FirooziComputer Engineering, Birjand Branch, Islamic Azad University Birjand Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organophosphorus (OPs) compounds can endanger human health and the environment by inhibiting the acetylcholinesterase enzyme. But these compounds have been widely used as pesticides due to their effectiveness against all kinds of pests. In this study, a Needle Trap Device (NTD) packed with mesoporous organo-layered double hydroxide (organo-LDH) material and coupled with gas chromatography-mass spectrometry (GC-MS) was employed for the sampling and analysis of OPs compounds (diazinon, ethion, malathion, parathion, and fenitrothion). In this way, the [magnesium-zinc-aluminum] layered double hydroxide ([Mg-Zn-Al] LDH) modified with sodium dodecyl sulfate (SDS) as a surfactant was prepared and characterized by FT-IR, XRD, BET, and FE-SEM, EDS, and elemental mapping techniques. Then, various parameters such as relative humidity, sampling temperature, desorption time, and desorption temperature were evaluated by the mesoporous organo-LDH:NTD method. The optimal values of these parameters were determined using response surface methodology (RMS) and central composite design (CCD). The optimal temperature and relative humidity values were obtained as 20 °C and 25.0%, respectively. On the other hand, the desorption temperature and time values were in the range of 245.0-254.0 °C and 5 min, respectively. The limit of detection (LOD) and limit of quantification (LOQ) were reported in the range of 0.02-0.05 mg m

Identifiers

PMID37312990
PMCPMC10258888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.